Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false date of answer exactly: or between: and previous answer version
creator	label
publisher
tabling member	label

Search

1138888

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	15/07/2019
	date tabled	15/07/2019
	ddp created	15/07/2019 18:42:26
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/07/2019 18:58:03 19/07/2019 10:18:02
	hansard heading	Sickle Cell Diseases: Health Services
	house id	1
	identifier	277137
	legislature	25259
	parliament number	57
	question first answered	19/07/2019 09:46:21
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 May 2019 to Question 256313 on Sickle Cell Diseases, which services (a) NHS England, (b) clinical commissioning groups and (c) other public bodies commission for people with sickle cell disease; and what the per capita annual cost is of providing each of those services.
	session	2017/19
	session number	1
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	title	House of Commons Tabled Parliamentary Question 2017/19 277137
	type	WrittenParliamentaryQuestion
	uin	277137
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction date of answer 19/07/2019 previous answer version 129855
	creator	1533 label Biography information for Dame Diana Johnson
	publisher	25259
	tabling member	1533 label Biography information for Dame Diana Johnson

1138889

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	15/07/2019
	date tabled	15/07/2019
	ddp created	15/07/2019 18:42:29
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/07/2019 18:58:05 19/07/2019 10:17:01
	hansard heading	Sickle Cell Diseases: Health Services
	house id	1
	identifier	277138
	legislature	25259
	parliament number	57
	question first answered	19/07/2019 09:45:39
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 May 2019 to Question 256313, which services (a) NHS England, (b) clinical commissioning groups and (c) other public bodies commission for sickle cell disease patients with (i) stroke, (ii) chronic kidney disease, (iii) end-stage renal disease and (iv) pulmonary hypertension; and what the annual per capita cost is of providing each of those services.
	session	2017/19
	session number	1
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	title	House of Commons Tabled Parliamentary Question 2017/19 277138
	type	WrittenParliamentaryQuestion
	uin	277138
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction date of answer 19/07/2019
	creator	1533 label Biography information for Dame Diana Johnson
	publisher	25259
	tabling member	1533 label Biography information for Dame Diana Johnson

1128812

	human indexable
	published
	registered interest
	answer date	06/06/2019
	date	03/06/2019
	date tabled	03/06/2019
	ddp created	03/06/2019 16:24:05
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	03/06/2019 16:25:29 06/06/2019 13:44:01
	hansard heading	Sickle Cell Diseases: Health Services
	house id	1
	identifier	259466
	legislature	25259
	parliament number	57
	question first answered	06/06/2019 13:13:01
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of potential levels of inequality in (a) the life expectancy and (b) NHS service provision for patients with sickle cell disease compared to other NHS patients.
	session	2017/19
	session number	1
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	title	House of Commons Tabled Parliamentary Question 2017/19 259466
	type	WrittenParliamentaryQuestion
	uin	259466
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction date of answer 06/06/2019
	creator	1533 label Biography information for Dame Diana Johnson
	publisher	25259
	tabling member	1533 label Biography information for Dame Diana Johnson

1127755

	human indexable
	published
	registered interest
	answer date	04/06/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 17:39:46
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/05/2019 17:46:14 04/06/2019 16:45:07
	hansard heading	Sickle Cell Diseases: Health Services
	house id	1
	identifier	256973
	legislature	25259
	parliament number	57
	question first answered	04/06/2019 16:13:21
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of NHS England’s planned restructuring of haemoglobinopathy services on (a) equitable access to services, (b) access to the most effective treatments, (c) access to highly specialised care and (d) quality of care in community-based settings for patients with sickle cell disease.
	session	2017/19
	session number	1
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	title	House of Commons Tabled Parliamentary Question 2017/19 256973
	type	WrittenParliamentaryQuestion
	uin	256973
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction date of answer 04/06/2019
	creator	1533 label Biography information for Dame Diana Johnson
	publisher	25259
	tabling member	1533 label Biography information for Dame Diana Johnson

1127756

	human indexable
	published
	registered interest
	answer date	04/06/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 17:39:48
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/05/2019 17:46:16 04/06/2019 16:45:05
	hansard heading	Sickle Cell Diseases: Health Services
	house id	1
	identifier	256974
	legislature	25259
	parliament number	57
	question first answered	04/06/2019 16:13:21
	question text	To ask the Secretary of State for Health and Social Care, if he will publish impact assessments of the potential effects of NHS England’s planned restructuring of haemoglobinopathy services on treatment of (a) all haemoglobinopathies and (b) sickle cell disease.
	session	2017/19
	session number	1
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	title	House of Commons Tabled Parliamentary Question 2017/19 256974
	type	WrittenParliamentaryQuestion
	uin	256974
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction date of answer 04/06/2019
	creator	1533 label Biography information for Dame Diana Johnson
	publisher	25259
	tabling member	1533 label Biography information for Dame Diana Johnson